论文部分内容阅读
目的:探讨不同温度雾化液雾化治疗慢性阻塞性肺疾病急性发作期中的临床疗效。方法:选取2012年~2014年在我院住院治疗的60例慢性阻塞性肺疾病急性发作期患者为研究对象,将其随机分为治疗组30例和对照组30例,将两组治疗前后的呼吸频率及指脉氧变化、肺功能变化、主要症状体征平均消失时间(痰量、咳嗽、喘鸣、湿啰音)进行比较。结果:经统计分析比较显示,治疗组呼吸频率及指脉氧变化、肺功能变化、主要症状体征平均消失时间均明显优于对照组,P<0.05,对比组之间的差异有统计学意义。结论:经加温后的雾化液雾化治疗,可明显增强患者的舒适性,改善临床症状、体征及肺通气功能,提高了氧合指数,从而提高了临床疗效。
Objective: To investigate the clinical effect of different temperature atomizing fluid atomization in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods: Sixty patients with acute exacerbation of chronic obstructive pulmonary disease who were hospitalized in our hospital from 2012 to 2014 were selected as study subjects. They were randomly divided into treatment group (30 cases) and control group (30 cases). Before and after treatment Respiratory rate and pulse oxygen changes, changes in lung function, the average disappearance of the main symptoms and signs of time (sputum volume, cough, wheezing, wet rales) were compared. Results: The statistical analysis showed that the respiratory rate of the treatment group and the change of the finger pulse oxygen, the change of pulmonary function and the average disappearance time of the main symptoms and signs were significantly better than those of the control group (P <0.05). The difference between the two groups was statistically significant. Conclusion: Atomized nebulized liquid after warm treatment can significantly improve patient comfort, improve clinical symptoms, signs and pulmonary ventilation, improve the oxygenation index, thereby improving the clinical efficacy.